Update on the phase III GOYA study in DLBCL
Educational theme: High-risk patients with lymphoid malignancies
Despite the plethora of regimens and the chemosensitivity of aggressive B-cell lymphomas, many patients fail to respond well to treatment. This article collates expert opinions...
Despite the plethora of regimens and the chemosensitivity of aggressive B-cell lymphomas, many patients fail to respond well to...
Prof. Marek Trneny | EBMT 2018 | What were the most interesting results from EBMT?
What were the most interesting results from EBMT?
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox